Wang Shuyun, Huang Jian, Mao Huijuan, Wang Yuliang, Kasimu Rena, Xiao Wei, Wang Jinhui
School of Traditional Chinese Materia Medica & Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
School of Pharmacy, Xinjiang Medical University, Urumqi 830054, China.
Molecules. 2014 Nov 4;19(11):17957-67. doi: 10.3390/molecules191117957.
A variety of traditional Chinese medical formulations contain two or more herbs from the same genus or family. Although these herbs may have a similar appearance and constituents, they usually have different pharmacodynamic actions. A series of qualitative and quantitative analysis methods are developed to determine one or more compounds for quality control of medicine. As far as we know, no method has been found to determine the real ratio of the two herbs along with the prescription. In this study, we used HPLC-DAD as a way to determine the content of Moutan cortex (M) and Paeoniae radix alba (P) in GuizhiFuling Wan (GZFLW). An effective, accurate and reliable HPLC-DAD method was developed for detecting the content of M and P in GZFLW through the analysis of four monoterpeneglycosides, namely, galloylpaeoniflorin (1), paeoniflorin (2), mudanpioside C (3) and benzoylpaeoniflorin (4). Due to the different UV characteristics of the compounds, the detection wavelength was 270 nm for 1 and 2, while 3 and 4 were monitored at 254 nm and 230 nm, respectively. Four equations were put forward to describe the relationship between content of M as well as P and the four monoterpene glycosides in GZFLW. After validation, all the accuracies of the M and P contents in GZFLW were within 10%. The result showed that the method could be successfully applied to analyze the contents of M and P in GZFLW. Moreover, our method may be more widely used to control the quality of proprietary Chinese medicines, especially for those containing the same genus or family herbs, in industrial GMP production.
多种中药配方含有两种或更多来自同一属或科的草药。尽管这些草药可能具有相似的外观和成分,但它们通常具有不同的药效作用。人们开发了一系列定性和定量分析方法来测定一种或多种化合物,以进行药品质量控制。据我们所知,尚未找到确定两种草药在方剂中的实际比例的方法。在本研究中,我们使用高效液相色谱 - 二极管阵列检测器(HPLC - DAD)来测定桂枝茯苓丸(GZFLW)中牡丹皮(M)和白芍(P)的含量。通过分析四种单萜糖苷,即没食子酰芍药苷(1)、芍药苷(2)、丹皮苷C(3)和苯甲酰芍药苷(4),开发了一种有效、准确且可靠的HPLC - DAD方法来检测GZFLW中M和P的含量。由于这些化合物的紫外特征不同,化合物1和2的检测波长为270 nm,而化合物3和4分别在254 nm和230 nm处进行监测。提出了四个方程来描述GZFLW中M和P的含量与四种单萜糖苷之间的关系。经过验证,GZFLW中M和P含量的所有准确度均在10%以内。结果表明,该方法可成功应用于分析GZFLW中M和P的含量。此外,我们的方法可能更广泛地用于在工业GMP生产中控制中成药的质量,特别是对于那些含有同一属或科草药的中成药。